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Abstract
Background: The prostate is a key gland in the sexual physiology of male mammals. Its sensitivity to
steroid hormones is widely known, but its response to prolactin is still poorly known. Previous studies
have shown a correlation between sexual behaviour, prolactin release and prostate physiology. Thus, here
we used the sexual behaviour of male rats as a model for studying this correlation. Hence, we developed
experimental paradigms to determine the influence of prolactin on sexual behaviour and prostate
organization of male rats.
Methods: In addition to sexual behaviour recordings, we developed the ELISA procedure to quantify the
serum level of prolactin, and the hematoxilin-eosin technique for analysis of the histological organization
of the prostate. Also, different experimental manipulations were carried out; they included pituitary grafts,
and haloperidol and ovine prolactin treatments. Data were analyzed with a One way ANOVA followed by
post hoc Dunnet test if required.
Results:  Data showed that male prolactin has a basal level with two peaks at the light-dark-light
transitions. Consecutive ejaculations increased serum prolactin after the first ejaculation, which reached
the highest level after the second, and started to decrease after the third ejaculation. These normal levels
of prolactin did not induce any change at the prostate tissue. However, treatments for constant elevations
of serum prolactin decreased sexual potency and increased the weight of the gland, the alveoli area and
the epithelial cell height. Treatments for transient elevation of serum prolactin did not affect the sexual
behaviour of males, but triggered these significant effects mainly at the ventral prostate.
Conclusion: The prostate is a sexual gland that responds to prolactin. Mating-induced prolactin release
is required during sexual encounters to activate the epithelial cells in the gland. Here we saw a precise
mechanism controlling the release of prolactin during ejaculations that avoid the detrimental effects
produced by constant levels. However, we showed that minor elevations of prolactin which do not affect
the sexual behaviour of males, produced significant changes at the prostate epithelium that could account
for triggering the development of hyperplasia or cancer. Thus, it is suggested that minute elevations of
serum prolactin in healthy subjects are at the etiology of prostate abnormal growth.
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Background
The prostate is a key gland in the sexual physiology of
male mammals.
Its location in the reproductive tract influences several
vital functions as those related to micturition, seminal
emission and ejaculation. In the rat, it is wrapping the
proximal region of the urethra, known as the prostatic
urethra, with a size that equals the empty bladder. The
prostate is a globular gland organized in two regions, the
dorsolateral or dorsal prostate and the bilobulated ventral
prostate. The histological observation of the gland reveals
that in the two regions it is organized in several alveoli
surrounded by the stroma area. Each alveolus is arranged
with a secretory epithelium that is in charge of the synthe-
sis of prostatic secretions, which are necessary for fertility.
The main type of epithelial cells has a columnar shape and
is the target for the endocrine stimulation of the gland.
Steroid hormones have a strong influence on the physiol-
ogy of the prostate. Androgen stimulation produces sev-
eral changes in the gland with differential effects on the
dorsal or ventral regions [1,2], and castration reduces sig-
nificantly the weight of the gland and alters the organiza-
tion of epithelial cells [3]. Among androgens,it has been
shown that the 5α-dihydrotestosterone is more potent
than testosterone to maintain some characteristics of the
prostate [4], but also is known that estrogens are impor-
tant for the maintenance of some functions of the gland
[5]. On the other hand, peptide hormones have received
considerably less attention regarding their role in prostate
function. However, it has been shown that prolactin
(PRL) has a biphasic influence on prostatic organization
[6], and that the prostate shows the expression of mRNA
for PRL receptors [7]. Thus, in this work we were inter-
ested in further investigate the effects of PRL on the organ-
ization of the prostate in sexually active male rats.
PRL is a hormone synthesized and secreted into the blood
by lactotrophs in the adenohypophysis. It participates in
different functions, of which those relating to reproduc-
tion have been studied the most. As is the case with other
hormones produced in the hypophysis, PRL displays a
variable serum level during the day. In adult rats it has
been shown that PRL peaks around the light-dark transi-
tion period [8,9]. Most studies of PRL in males have
focused on an analysis of its abnormally high levels,
known as hyperprolactinemia (hyperPRL). Subjects with
hyperPRL show a severe effect in the potency for penile
erection [10,11]. In the behavioural context, hyperPRL
males can initiate copulation but either do not ejaculate
or show a significant reduction in their ejaculatory poten-
tial [12,13]. Hence, hyperPRL males generally take a
longer time to ejaculate than control males [12-15], with
a concurrent higher number of mounts and lower number
of intromissions [12,13,15-17]. The time course effect of
hyperPRL on sexual behaviour seems to be around 10 to
15 days [14,15]. Notwithstanding these findings, every
study confirms that a constant, high level of PRL reduces
the sexual function of males. In contrast, a transient eleva-
tion of endogenous PRL is observed during the sexual
behaviour of male rats or in males attempting to copulate
with nonestrous females, and the execution of the behav-
iour is necessary since the odor alone from estrous
females is unable to cause this increase [18]. Additionally,
an acute or chronic treatment to induce an increase of PRL
in male rats results in a respective stimulatory or inhibi-
tory modification of sexual behaviour [19]. This means
that in contrast to constant conditions, a brief surge of
PRL seems necessary for a proper expression of sexual
function in males.
In view of this information, it is clear that there is a corre-
lation between sexual behaviour, PRL release and prostate
physiology. The correlation seems unidirectional since
sexual activity influences prostatic function, but the lack
of the prostate does not alter the behavioural context [20].
Thus, here we used the sexual behaviour of male rats as a
model for studying this correlation. This behaviour in rats
has a well-known stereotyped pattern. Males display sev-
eral mounts and intromissions before ejaculation, and all
these parameters occur recurrently in such a way that a
male can achieve several ejaculatory series in a single sex-
ual encounter. Taking advantage of this behavioural pat-
tern, we developed experimental paradigms to determine,
in a longitudinal study, the influence of sexual behaviour
on the level of PRL and prostate organization in male rats
displaying up to four consecutive ejaculations.
Methods
Subjects and housing
Sexually experienced Wistar male rats were used (250–
300 g/bw). Males were living in a room with an inverted
light-dark cycle (12–12 hr, lights off at 0800 hrs). Every rat
was manipulated daily, hence they were habituated to
experimenter contact and to the environment in order to
avoid the stress-induced PRL release. Ovariectomized
females were used, and their sexual receptivity was
induced with steroids, dissolved in sesame oil. Accord-
ingly, subcutaneous injections of estradiol benzoate (10
μg) and then progesterone (2 mg) were administered 48
and 4 hrs before tests, respectively. Rats were housed in
plastic cages (50 × 30 × 20 cm) containing wood chip bed-
ding and rooms were under a controlled temperature (22
± 2°C), with food (Harlan Mexico rodent chow) and
water available ad libitum. Every surgical intervention and
manipulation of rats was guided by the Society for Neuro-
science Policy on the Use of Animals in Neuroscience
Research.Reproductive Biology and Endocrinology 2006, 4:28 http://www.rbej.com/content/4/1/28
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Experiment 1
This experiment was designed to obtain the baseline levels
of serum PRL in the dark phase. Four groups were formed:
G8 (n = 10), G12 (n = 12), G16 (n = 12), and G20 (n =
12). The number indicates the hour of the day on which
blood was collected, such that the term 'G12' would indi-
cate the sample was taken at 12:00 hrs. Males were cannu-
lated for blood collection (see below) two days before the
beginning of the experiment. Blood samples (0.2 ml)
were collected once per animal on the hour indicated by
the group, but samples at 08:00 hrs were taken about 5
minutes after the designated hour, and samples at 20:00
hrs were taken about 5 minutes before the designated
hour.
Males were cannulated for blood collection. They were
anesthetized with sodium pentobarbital (Smith Kline,
Mexico; 30 mg/kg bw, i.p.), and the right jugular vein was
exposed. The vein was half-cut and 2.5 cm of a cannula
(Dow Corning, USA, 0.30 mm ID and 0.64 mm OD)
introduced to leave the tip in the right atrium. The can-
nula and vein were fixed and a small loop of the cannula
was positioned in the ventral neck area to avoid displace-
ment during head movements. The other side of the can-
nula was guided subcutaneously to the back and exposed
through a hole made in the skin. The skin in the neck was
sutured, covering the cannula and loop. Therefore, only
the end of the cannula in the back was exposed. It was
filled with saline solution with a Hamilton syringe, the tip
was closed with a small metal plug, and it was covered
with a belt (1.5 cm wide) that surrounded the thoracic
area of the body. The belt was lab-made for this experi-
ment and was designed for two purposes: to protect the
cannula from male scratching movements, and to allow
the male to copulate without any interference. Cannu-
lated males were placed alone in a cage. To collect blood,
a small drop of a heparin solution was placed in a Hamil-
ton syringe. The syringe was connected to the tip of the
cannula and blood extracted and mixed inside the syringe
with the heparin solution. After blood collection, a sec-
ond Hamilton syringe was connected to the cannula to
inject 0.2 ml of saline solution to wash most of the blood
left inside the cannula and to avoid coagulated plugs.
Blood samples were centrifuged, and the plasma obtained
was stored at -20°C until assayed.
PRL levels in plasma samples were measured using the
ELISA procedure. A 96 well plate was coated with PRL
(NIDDK-rPRL-I-6) at a 10 ng/50 μl concentration in car-
bonate buffer (sodium carbonate 0.1 M, and sodium
bicarbonate 0.035 M), and incubated at 4°C for 24 hr. On
the other hand, using eppendorf tubes, PRL standard
curves were done in triplicate at several concentrations in
PBS 0.1 M and Tween 20 0.05% (concentrations: 120, 60,
30, 25 and 7.5 ng/ml). Also, both diluted plasma samples
(1:6) and standard curves were incubated in parallel with
the first antibody (1/100, NIDDK-anti-rPRL-RP-3) over-
night at 4°C. Then, the plate was washed (3 times, 5 min
each) with PBS-Tween 20 solution, followed by the add-
ing of bovine serum albumin 1% for an hour, and washed
once for 3 min with the PBS-Tween 20 solution. 50 μl of
standard curve and plasma sample were took, added to
the wells, and incubated at 4°C for 24 hr. Again, the plate
was washed (3 times, 3 min each) with PBS-Tween 20
solution, incubated with the second peroxidase-conju-
gated antibody (1/800) at room temperature for 2 hr, and
washed (3 times, 5 min each) with PBS-Tween 20 solu-
tion. The plate was developed with orthophenildiamine
(10 mg) and hydrogen peroxide (3%) in citrate buffer (cit-
ric acid 0.05 M, and dibasic sodium phosphate 0.1 M) for
10 min, and stopped with cold sulphuric acid (4 N). The
plate was read at 490 nm. The sensitivity was about 3 ng/
ml, and intra and interassay coefficient variations were 9.2
and 15.5% respectively.
Experiment 2
The experimental paradigm of this study was used to
determine the effect of consecutive ejaculations (up to 4)
on the level of serum PRL and on the histology of the ven-
tral and dorsal prostate. Males were prepared for blood
collection two days before the beginning of tests, and
females were treated appropriately to induce a state of sex-
ual receptivity. Experiments were carried out under red
light between 12:00 and 16:00 hrs, the time considered
ideal for the proper execution of sexual behaviour in rats
[21]. A male rat was taken from its cage and a blood sam-
ple obtained (0.2 ml). It was then placed in a Plexiglas
arena (60 cm diameter × 60 cm high), and a receptive
female was introduced five minutes later. Parameters
detailing the sexual behaviour of the male were recorded
immediately [22], but only the Hit Rate parameter is
showed in results for the last experiment; it is a proportion
obtained after the computation of the number of
intromissions divided by the sum of the number of
intromissions and the number of mounts [23]. This is a
good indicator of the appropriate execution of male's sex-
ual behaviour.
The number of consecutive ejaculations marked the
assigned group of the animal. Males from group E1 (n =
17) were allowed to ejaculate once, and then a post-ejac-
ulatory blood sample was obtained. Group E2 (n = 13)
males were allowed to ejaculate twice, group E3 (n = 12)
males were allowed three ejaculations, and group E4 (n =
12) males were allowed four ejaculations, with post-ejac-
ulatory blood samples being obtained after the final ejac-
ulatory event of each male. Every animal was thus
sampled twice per test: once before and once after its ejac-
ulatory series, and samples analyzed with the ELISA pro-
cedure. On the other hand, about 50% of males in eachReproductive Biology and Endocrinology 2006, 4:28 http://www.rbej.com/content/4/1/28
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group were killed after its respective ejaculation, the pros-
tate obtained, weighed and prepared for histology with
the hematoxilin-eosin stain.
The stain with hematoxilin-eosin started by immersing
the prostate for 24 h in Helly fixative (Mercuric Chloride
5%, Potassium Dichromate 2.5%, Sodium Sulfate 1%,
and Formalin 37%); then the fixative was washed with tap
water for 30 min. Dehydration was carried out by immers-
ing the prostate in ethanol 70% (1 hr), 80% (1 hr), 96%
(3 times, 2 hrs each), absolute ethanol (overnight), and
absolute ethanol (2 times, 1 hr each). Clearing was done
by immersing the prostate in xylene (3 times, 1 hr each).
Both dehydration and clearing were carried out under
continuous shaking. Then, the prostate was embedded in
melted paraffin (2 times, 2 hr each at 57°C) and a block
was done by using a microtome cassette. The paraffin
block was sectioned on a Leica microtome (5 μm). Sec-
tions were placed on a mounting bath with gelatinized
water at 52°C and tissues mounted on slides that were
placed for 1 hr in an oven (~58°C). For staining, tissues
were immersed in xylene (3 times, 5 min each), absolute
ethanol/xylene 1:1 (5 min), ethanol 96% (3 min), iodine
alcohol (5 min), sodium thiosulfate (10 min), tap water
(2 min), Mayer's Hematoxilin (10 min), tap water (30
sec), acid ethanol (fast bath), tap water (10 sec), lithium
carbonate (30 sec), tap water (10 sec), Eosin Y (4 fast
baths), ethanol 96% (3 min), absolute ethanol (2 min),
absolute ethanol/xylene 1:1 (2 min), and xylene (5 min).
Finally, sections were coverslipped with undiluted Per-
mount. Each slide had sections from just one region of the
prostate, i.e., we obtained ventral slides and dorsolateral
slides. The slides were observed in an Olympus Provis AX-
70 microscope, and images obtained and analyzed with
the Image-Pro Plus software. Measures obtained were the
height of epithelial cells and the area of the alveoli.
Experiment 3
This experiment was done to determine the effect on the
prostate of treatments that are known to increase PRL
serum level and decrease sexual behaviour. Three groups
of males were used (n = 6 each): control males (without
treatment); males treated with haloperidol; and males
with a pituitary graft under the kidney capsule. After 15
days of treatment, males were killed, the prostate
obtained, weighed and prepared for histology with the
hematoxilin-eosin stain. Blood samples were also
obtained from these males to get the profile of PRL in
serum. Haloperidol was administered with implants that
consisted of silastic capsules (10 mm long, 1.58 mm i.d.,
3.06 mm o.d.) filled with the crystalline drug (~9 mg).
The capsule was placed subcutaneously in the nape of the
neck under ether anaesthesia. Pituitary grafts were
obtained from a donor male that was killed immediately
after pituitary removal.
Experiment 4
In this experiment, a controlled administration of exoge-
nous PRL was used to determine the effect on the prostate
of sexual behaving males. Three groups of males were
used (n = 30 each): Intacts with no treatment, Vehicle
injected and PRL injected. Treated males were injected
subcutaneously with two daily doses (10:00 and 18:00
hrs) of vehicle or ovine PRL. On day 3 after the beginning
of treatments, every male was tested for sexual behaviour.
Then, 6 males of each group were killed, the prostate
obtained, weighed and prepared for histology with the
hematoxilin-eosin stain. Blood samples were also
obtained from these males to get the profile of PRL in
serum. Remaining males were returned to the animal
room and the same procedure repeated on days 6, 9, 12
and 15.
Ovine PRL was obtained in bottles of 33.3 μg (Sigma
Chemical, Mexico) that were diluted in injectable grade
water (14.5 ml) to obtain a concentration of 100 μM. 100
μl of this stock solution was diluted (1:4) in the injectable
water. 100 μl of this final solution were in each dose
injected to experimental males (~50 μg of PRL per dose).
Statistics
Nonparametric statistics were used in Experiments 1 and
2. Between-group comparisons of data from Experiment 1
were made with Kruskal-Wallis (KW) analysis of variance,
and paired contrasts were obtained with Mann-Whitney
(MW) tests. PRL data from Experiment 2, comparing pre-
and post-ejaculatory results of correlated groups, were
analyzed with the Wilcoxon Signed-Rank test. Experiment
3 and 4 were analyzed with a One Way ANOVA followed
by the post hoc Dunnet test when the F value showed sig-
nificant differences at p < 0.05. In every statistics, signifi-
cant differences were inferred when p < 0.05.
Results
Experiment 1
PRL was detected in every plasma sample analyzed. How-
ever, the concentration was different depending on the
hour of the day in which the sample was taken. Statistical
analysis showed that PRL had overall differences, and MW
tests revealed significant differences between the samples
at 12:00 and 16:00 hrs and those taken at the transition
between the dark-light and light-dark phases. A consider-
ation of all the data reveals that the lowest PRL concentra-
tion (~12 ng/ml) represents the baseline of the hormone,
with two significant peaks being evident at the dark-light-
dark transitions which increased the PRL concentration to
~38 ng/ml (Fig. 1).
Experiment 2
PRL levels showed a brief but significant increase after
consecutive ejaculations. As expected, a quantity of PRLReproductive Biology and Endocrinology 2006, 4:28 http://www.rbej.com/content/4/1/28
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was detected before the male was introduced to the sexual
behaviour arena, with this concentration ~18 ng/ml being
similar to the baseline obtained in Experiment 1. The con-
centration of serum PRL was significantly higher in sam-
ples taken after the first, second and third ejaculations in
comparison to its paired precopulatory value, but after the
second ejaculation the level of PRL reached its maximum.
A Gauss-like curve of PRL was therefore detected (Fig. 1).
It started to rise after the first ejaculation (~35 ng/ml, p <
0.05), formed a peak after the second ejaculation (~80 ng/
ml, p < 0.01), started to decrease after the third ejaculation
though still remaining high (~45 ng/ml, p < 0.05), and
after the fourth ejaculation the PRL concentration
returned to baseline levels. Placing this data on the curve
of PRL quantified between 12 and 16 hr of Experiment 1
reveals that sexual behaviour causes a temporary and sig-
nificant increase of PRL release, even to a level that is
higher than the peak observed in the dark-light-dark tran-
sitions (Fig. 1).
Histological observations of the prostate showed that con-
secutive ejaculations did not produce any change on the
tissue (data not shown). Every data regarding control
males in the next two experiments are equivalent to the
tissue parameters observed here.
Experiment 3
The continuous elevation of serum PRL (Fig. 2) by admin-
istration of haloperidol (Hal) or adenohypophysis (Adh)
transplant produced significant effects on the prostate tis-
sue (Fig. 3 and 4). The weight of the gland increased after
both treatments, but the Adh produced a higher increase
in the ventral prostate (Fig. 5). The alveoli area increased
significantly in both regions of the prostate after Adh;
however, Hal produced an increase only at the dorsal
region without affecting the ventral prostate (Fig. 5). The
epithelial cells height increased significantly in the ventral
prostate after Adh or Hal, but there was not any change at
the dorsal region (Fig. 5).
Experiment 4
The exogenous controlled-administration of PRL pro-
duced transient elevations of serum PRL (Fig. 2) and sig-
nificant effects on the prostate tissue without affecting the
sexual behaviour of males. The weight of the gland
remained constant in both the ventral and dorsal regions
(Fig. 6). However, the alveoli area at the ventral region
showed a significant decrease after 12 days; the opposite
effect was observed for the dorsal region, but a significant
value was only seen after 15 days of treatment (Fig. 6). The
epithelial cells height increased significantly after 9 days
of treatment in both the ventral and dorsal prostate (Fig.
6). As an indicator that the sexual behaviour was not
affected, Fig. 7 shows the Hit Rate parameter.
Discussion
Our data show that male PRL has a basal level with two
peaks at the light-dark-light transitions. These findings
support the work of other researchers who have reported
one or two peaks under different experimental conditions
[8,24]. The fluctuation of PRL levels could be useful for a
number of bodily functions. It has been shown that PRL
serves to potentiate the effect of androgens on the acces-
sory glands and on the increase of luteinizing hormone
receptors in Leydig cells, that in turn increases testoster-
one synthesis [25]. Maintenance of the testis therefore
seems to be a key function of PRL, and here we showed
that PRL is also important for the physiology of the pros-
tate.
Consecutive ejaculations in the same day have a strong
effect on the transient release of PRL in serum. A signifi-
cant increase of PRL was observed after the first ejacula-
tion, and reached the highest level after the second
ejaculation. The level of PRL then started to decrease. After
the third ejaculation it was still significantly elevated, and
by the fourth ejaculation it returned to pre-copulatory lev-
els. A question arising from these results focuses on deter-
mining the parameter of sexual behaviour that is
triggering the release of PRL. Attempts by males to copu-
late with nonestrous females (mounting, without
Serum levels of PRL Figure 1
Serum levels of PRL. The graph represents the compari-
son of basal values (sine wave) and the values produced after 
consecutive ejaculations between 12 and 16 hrs (bars). Signif-
icant changes are shown just for bars. The white bar is a rep-
resentative value of the level of PRL obtained before sexual 
behaviour. Gray bars represent the values obtained after 
each of the four consecutive ejaculations (mean ± SEM). 
Asterisks represent significant changes (* = p < 0.05, ** = p < 
0.01) in comparison to the paired white bar of each group. 
The mating-induced PRL is transient and reached higher val-
ues after the second ejaculation; ng/ml = nanograms per mil-
lilitre.Reproductive Biology and Endocrinology 2006, 4:28 http://www.rbej.com/content/4/1/28
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intromissions) stimulate PRL release [26], and here we
also showed that the serum level of PRL fluctuates in a
specific pattern after one or more ejaculations. Thus, it
seems that the values we recorded are the sum of individ-
ual influences of mounts, intromissions and ejaculations.
However, further studies are needed to determine the
extent of the influence of each copulatory parameter in
this process. A remarkable observation was the fact that
the second copulatory series triggered the maximal con-
centration of PRL in serum. Considering that the third and
fourth ejaculatory series were unable to produce a higher
elevation of PRL, we would like to suggest a mechanism to
account for these observations. The first copulatory series
primes the system for a maximal response after the second
ejaculatory series. The highest PRL level observed after the
second ejaculation then triggers a long refractory period
that makes the system controlling the release of PRL unre-
sponsive to the influence of further mounts, intromis-
sions and ejaculations. As a consequence, PRL starts to
decrease (post-third ejaculation value) until it reaches its
baseline level (post-fourth ejaculation value).
PRL has an important influence on male reproduction by
modulating the histological structure of the prostate. It is
known that PRL receptors are expressed in the epididymis,
seminal vesicle and prostate [7]. Consequently, the
increase of PRL during the first and second copulatory
series could serve to trigger the synthesis and release of the
contents of these glands in order to have a sufficient quan-
tity of semen to expel in each ejaculation. Here we showed
that the chronic increase of PRL, by Hal or Adh transplant,
had significant effects on the prostate, although Adh
transplant produced more effects than Hal treatment. The
weight of the gland and the alveolar area increased signif-
Serum levels of PRL after Treatments Figure 2
Serum levels of PRL after Treatments. The graph represents the estimated daily profile of PRL in serum after experimen-
tal treatments. Lines show the comparison between basal values () and the values obtained after treatments with haloperidol 
(), pituitary grafts transplants (), and ovine PRL administration (●). Thus, the experimental paradigms allowed continuous 
levels and transient levels. Each point represents the mean value. The profile induced by sexual behaviour is not represented 
(see Fig. 1).Reproductive Biology and Endocrinology 2006, 4:28 http://www.rbej.com/content/4/1/28
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icantly, and the epithelial height also increased but only
at the ventral region of the prostate. Thus, Adh transplants
and Hal treatments produced similar effects on the pros-
tate after inducing high and continuous level of serum
PRL, similar to other reports too [27,28]. The mechanism
of PRL to induce these changes is unknown, but as
Histology of the Ventral Prostate Figure 3
Histology of the Ventral Prostate. Examples of images obtained after the different treatments. The left column represents 
the effect on alveoli, and the right column the effect on the epithelium. The top row shows the histology in intact (Ctrl) sub-
jects, while the middle shows increments (Inc; from Experiment 3, see Fig. 5) and the bottom decrements (Dec; from Experi-
ment 4, see Fig. 6) of the parameters. A decrement in the epithelium was never observed, so there is not a picture to show. 
Left scale bar = 250 μm; Right scale bar = 10 μm.Reproductive Biology and Endocrinology 2006, 4:28 http://www.rbej.com/content/4/1/28
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described by other authors [29-31], this hormone has a
number of effects at the prostate tissue as those related to
citrate production, apoptosis decrease by overexpression
of Bcl-2, or synergistic effects with androgens. Accord-
ingly, we hypothesize that the observed growth of differ-
ent histological parameters of the gland is related to an
increased synthesis and release of its contents to the alve-
oli area. Whether the content is citrate or another com-
pound is a topic that still deserves further research.
Furthermore, as widely described, our work also showed
that the prostate is a complex gland, since each lobule
seems to have its own molecular characteristics respond-
ing differently to the same treatment.
Our final experiment showed that the periodic execution
of sexual behaviour, producing transient elevations of
serum PRL, do not induce any change in the prostate tis-
sue. However, the exogenous administration of ovine PRL
at a dose that does not affect copula parameters showed
that the weight of the gland did not change, the alveolar
area decreased with time only at the ventral region, and
the epithelial height increased in the ventral and dorsal
regions but with a higher magnitude at the ventral pros-
tate. Hence, it is clear that the prostate tissue is capable to
function properly during continuous copulation without
changing its structure, but after a slight increase in serum
PRL the gland has reactions mainly at the epithelium. Epi-
thelial cells response could be due to an increased expul-
sion of semen or to a decreased potency of the cell to
synthesize its product, as suggested by the area decrease of
alveoli. These suggestions are supported by other reports
showing that PRL in the prostate epithelial cells modifies
Histology of the Dorsal Prostate Figure 4
Histology of the Dorsal Prostate. Examples of images obtained after the different treatments. The left column represents 
the effect on alveoli, and the right column the effect on the epithelium. The top row shows the histology in intact (Ctrl) sub-
jects, while the bottom shows increments (Inc) of the alveoli area (from Experiment 3, see Fig. 5) and epithelial height (from 
Experiment 4, see Fig. 6). Neither decrement in the alveoli nor in the epithelium was observed, so there is not a picture to 
show. Left scale bar = 250 μm; Right scale bar = 10 μm.Reproductive Biology and Endocrinology 2006, 4:28 http://www.rbej.com/content/4/1/28
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Prostate responses to constant levels of PRL Figure 5
Prostate responses to constant levels of PRL. The increase of serum PRL after treatment with haloperidol (H) or after 
an adenohypophysis graft under the kidney capsule (Adh) produced increments in the three measured parameters. However, 
the ventral and dorsal regions of the prostate exhibited some differences, i.e., H did not modify the alveoli area at the ventral 
prostate, and both Adh and H did not modify the epithelium height at the dorsal prostate. Gray bars are compared vs. the 
white bar representing the control (C) value. * = p < 0.05; ** = p < 0.01.Reproductive Biology and Endocrinology 2006, 4:28 http://www.rbej.com/content/4/1/28
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Prostate responses to a small dose of PRL insexually active males Figure 6
Prostate responses to a small dose of PRL insexually active males. The treatment with daily doses of ovine PRL () 
in sexually active males did not modify the weight of the prostate. However, a decrement was observed in the alveoli area of 
the ventral prostate, and also it was observed a reliable increase of this parameter in the dorsal prostate after 15 days of treat-
ment or fifth behavioural test. The epithelium height was increased starting at the day 9 or third behavioural tests in both 
regions of the prostate. The incremental slope was constant with a higher magnitude at the ventral prostate. No modification 
was observed in untreated () or vehicle treated (●) males. * = p < 0.05; ** = p < 0.01.Reproductive Biology and Endocrinology 2006, 4:28 http://www.rbej.com/content/4/1/28
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the organelles in charge of protein synthesis and secretion
[32], that PRL produces an increased number of prostate
androgen receptor [33], and that PRL along with testoster-
one modulates the activity of enzymes associated with cit-
rate production [34]. Hence, a number of changes are
observed at the epithelial cells in response to a slight
increase of PRL. Here, we showed that PRL has a transient
elevation after consecutive ejaculations in the same sexual
encounter, and that a mechanism exists to inhibit further
increase after a third ejaculation. This inhibition could
account for a protection of tissues, like the prostate, to
maintain its normal organization and function. Thus, our
set of experimental paradigms showed that the prostate
tissue is highly sensitive to minute elevations of serum
PRL beyond the normal levels, which does not affect the
health or behaviour of the subject. Our suggestion then, is
that this minute elevation of PRL could be at the etiology
of prostate hyperplasia and/or cancer. It is known, in
humans, that hyperprolactinemia is frequent in both
breast and prostate cancer [35,36]. Then, it is suggested
that a serum PRL test could be useful to predict the begin-
ning of prostate abnormal growing, even before the pros-
tate-specific antigen appears in serum and much before
prostate cancer symptoms occur.
Conclusion
The prostate is a sexual gland that responds to prolactin.
Mating-induced prolactin release is required during sexual
encounters to activate the epithelial cells in the gland.
Here we saw a precise mechanism controlling the release
of prolactin during ejaculations that avoid the detrimental
effects produced by constant levels. However, we showed
that minor elevations of prolactin which do not affect the
sexual behaviour of males, produced significant changes
at the prostate epithelium that could account for trigger-
ing the development of hyperplasia or cancer. Thus, it is
suggested that minute elevations of serum prolactin in
healthy subjects are at the etiology of prostate abnormal
growth.
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